Inovio Pharmaceuticals, Inc. (INO) Q4 FY25 Earnings Call

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-13
Length36 minutes
EPS$0.31

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All INO earnings ยท Back to INO overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.